# Compass Therapeutics, Inc.: Form 8-K, filed Apr 19, 2021

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2021-04-19
- Accepted by EDGAR: Apr 19, 2021, 20:00 ET
- Period: 2021-04-14
- Accession: 0001564590-21-019394
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000156459021019394/cmpx-8k_20210414.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000156459021019394/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000156459021019394/cmpx-8k_20210414.htm

Filed Apr 19, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-019394. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.